Genomic Valley Biotech has informed that the meeting of Board of Directors of the Company is scheduled to be held on Monday, 07th October, 2024 at the Corporate Office of the Company, to transact the following business items with the permission of the Chair, if any: To consider and approve the unaudited financial results (standalone) of the Company for the quarter and half year ended September 30, 2024; To consider any other matter with the permission of the chairman. Further, pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 read with Company’s code for prevention of Insider trading, the, trading window for dealing in securities of the Company is closed from October 01, 2024 until the end of 48 hours after the results are made public on 07th October, 2024 for the Directors, KMPs, Promoters & Promoters Group and Designated Persons etc. covered under the code.
The above information is a part of company’s filings submitted to BSE.